Assessment of Real-World Performance of CELOX™ Rapid by Emergency Physicians and Trained Emergency Responders

Introduction . This study evaluates the real-world performance of CELOX™ Rapid, a chitosan-based haemostatic gauze, when used by emergency physicians and trained responders in UK pre-hospital and emergency care settings. Method . Data was drawn from 84 clinical cases submitted as part of a Post-Market Clinical Follow-Up (PMCF) survey. Results . The results demonstrated 100% haemostasis on first application, no reported adverse events, and high user satisfaction. Among a subset of users providing time-to-haemostasis data, 81% achieved bleeding control within one minute, and 94% within two minutes. Conclusion . These findings highlight CELOX™ Rapid’s rapid and reliable performance across a range of trauma mechanisms and patient profiles, including those on anticoagulation therapy. The results support the product’s continued inclusion in emergency medical kits and call for further research to establish comparative efficacy and long-term outcomes across diverse healthcare systems.